期刊文献+

稳定表达BCR/ABL的小鼠BaF3-P210细胞株的建立及其生物学特性的研究 被引量:11

Construction of BaF3-P210 cell line stably expressing BCR/ABL protein and its biological activity
下载PDF
导出
摘要 目的构建能稳定表达BCR/ABL的小鼠转化细胞株BaF3-P210,并初步探讨BCR/ABL对BaF3细胞生物学特性的影响。方法将含有bcr/abl基因的逆转录病毒载体转染到包装细胞,收集病毒感染BaF3细胞,经筛选和亚克隆,获得稳定表达BCR/ABL的转基因BaF3-P210细胞。用PCR、DNA测序、RT-PCR和Westernblot检测bcr/abl基因在靶细胞中的整合和表达;用台盼蓝细胞计数法、流式细胞仪(FCM)和MTT法研究BCR/ABL对BaF3细胞生物学特性的影响。结果bcr/abl基因整合在BaF3细胞基因组中,BaF3-P210细胞能稳定表达bcr/abl基因及其蛋白。与对照组相比,BaF3-P210细胞增殖速度增快(P<0.05);G0/G1期细胞比例下降,S期和G2/M期细胞比例增高(P<0.05);经STI571处理后的细胞增殖抑制率为(54.08±1.90)%(P<0.05),早期凋亡率为(12.35±2.04)%(P<0.05)。结论成功构建的能稳定表达BCR/ABL的小鼠BaF3-P210转化细胞株具有增殖能力增强、细胞周期进程加速和对STI571敏感的恶性表型特征。 Objective To construct the transformed mouse BaF3-P210 cell line stably expressing BCR/ ABL and to initially investigate the influence of BCR/ABL on the cell biological characteristics of BaF3 cell line. Methods The retroviral vector with bcr/abl gene was transfected into the packaging cell line. The BaF3 cells were infected with the collected viral supernatant. The transgenic BaF3-P210 cell line stably expressing BCR/ABL were screened and subcloned. The integration of the bcr/abl gene in the genome of the target cell was determined by PCR and DNA sequencing, trypan blue staining assay, flow cytometry and MTT assay. Results The bcr/abl gene was integrated into the BaF3 cell genome; RT-PCR and Western blot verified the stable expression of the bcr/abl gene and protein in the screened subclone cell line BaF3-P210. Compared with the control group, the cell proliferation rate was promoted ( P 〈 0.05 ) , and the cell proportion in G0/G1 phase was decreased with the increasing of the cell proportion in both S and G2/M phase ( P 〈 0.05 ) ; the cell proliferation inhibition rate and the early apoptosis rate of the BaF3-P210 ceils were respectively (54.08 ± 1.90)% (P 〈 0.05) and ( 12.35 ± 2.04) % ( P 〈 0. 05 ) after the treatment of protein tyrosine kinase inhibitor STI571. Conclusion The transformed mouse BaF3-P210 cell line stably expressing BCR/ABL was successfully constructed. The expression of BCR/ABL not only promoted the proliferation, but also accelerated the cell cycle progression of the BaF3 cells. It endowed the BaF3-P210 transformed cell line with the sensitivity to STI571.
出处 《第三军医大学学报》 CAS CSCD 北大核心 2008年第19期1791-1794,共4页 Journal of Third Military Medical University
基金 教育部高等学校博士学科点专项科研基金(20050631007)~~
关键词 慢性粒细胞白血病 BCR/ABL融合基因 逆转录病毒载体 BaF3细胞 chronic myeloid leukemia bcr/abl fusion gene retroviral vector BaF3 cell line
  • 相关文献

参考文献7

  • 1Goldman J M, Melo J V. Chronic myeloid leukemia-advances in biology and new approaches to treatment [ J ]. N Engl J Med,2003,349 (15) : 1451 - 1464. 被引量:1
  • 2Pear W S, Miller J P, Xu L, et al. Efficient and rapid induction of a chronic myelogenous leukemia-like myeloproliferative disease in mice receiving P210 bcr/abl-transduced bone marrow [ J ]. Blood, 1998,92 (10) :3780 - 3792. 被引量:1
  • 3Jin A, Kurosu T,Tsuji K,et al. BCR/ABL and IL-3 activate Rapl to stimulate the B-Raf/MEK/Erk and Akt signaling pathways and to regulate proliferation, apoptosis, and adhesion [ J ]. Oncogene, 2006,25 (31) :4332 -4340. 被引量:1
  • 4Parada Y, Banerji L, Glassford J, et al. BCR/ABL and interleukin 3 promote haematopoietic cell proliferation and survival through modulation of cyclin D2 and P27Kip1 expression[ J]. J Biol Chem, 2001,276 (26) :23572-23580. 被引量:1
  • 5Corradini F, Cesi V, Bartella V, et al. Enhanced proliferative potential of hematopoietic cells expressing degradation-resistant c-Myb mutants [ J ]. J Biol Chem, 2005,280 (34) :30254 - 30262. 被引量:1
  • 6Andreu E J, Liedo E, Poch E, et al. BCR-ABL induces the expression of Skp2 through the PI3K pathway to promote p27Kip1 degradation and proliferation of chronic myelogenous leukemia cells [ J ]. Cancer Res, 2005,65 ( 8 ) :3264 - 3272. 被引量:1
  • 7Chu S,Li L,Singh H,et al. BCR-tyrosine 177 plays an essential role in Ras and Akt activation and in human hematopoietic progenitor transformation in chronic myelogenous leukemia [ J ]. Cancer Res, 2007,67 (14) :7045 -7053. 被引量:1

同被引文献93

  • 1孟凡义.分子信号传导靶点阻断剂治疗慢性粒细胞白血病应注意的问题[J].中华医学杂志,2005,85(16):1082-1084. 被引量:4
  • 2罗建飞,陈必成,陈忠华.小鼠骨髓来源树突状细胞和DC2.4形态与功能比较[J].中国康复,2005,20(3):145-146. 被引量:9
  • 3庄亮,于世英,黄晓园,曹阳,熊慧华.DNA双链断裂修复蛋白表达水平与肿瘤细胞放射敏感性的关系研究[J].肿瘤,2007,27(4):281-285. 被引量:1
  • 4SLUPIANEK A, SCHMUTTE C, TOMBLINE G, et al. BCR/ ABL regulates mammalian ReeA homologs,resulting in drug resistance[J]. Mol Cell, 2001,8(4) :795-806. 被引量:1
  • 5MAJSTEREK I, SLUPIANEK A , HOSER G, et al. ABL-fusion oncoproteins activate multi-pathway of DNA repair: role in drug resistance? [J]. Biochimie, 2004,86(1) :53-65. 被引量:1
  • 6YANG J, HOOPER W C, PHILLIPS D J, et al. Regulation of proinflammatory cytokines in human lung epithelial cells infected with mycoplasma pneumoniae [ J ]. Infect Immun, 2002,70 ( 7 ) : 3649-3655. 被引量:1
  • 7RINK L, SLUPIANEK A, STOKLOSA T, et al. Enhanced phosphorylation of Nbsl, a member of DNA repair/checkpoint complex Mre11-RAD50-Nbs1, can be targeted to increase the efficacy of imatinib mesylate against BCR/ABL-positive leukemia cells[ J]. Blood, 2007, 110(2) :651-660. 被引量:1
  • 8IARGHERO J, LEGUAY T, MOURAH S, et al. Relationship between elevated levels of the alpha 1 acid glycoprotein in chronic myelogenous leukemia in blast crisis and pharmacological resistance to imatinib ( Gleevec ) in vitro and in vivo [ J ]. Biochem Pharmacol,2003,66 (10) : 1907-1913. 被引量:1
  • 9SKORSKI T. BCR/ABL regulates response to DNA damage: the role in resistance to genotoxic treatment and in genomic instability [ J ]. Oncogene,2002,21 (56) : 8591- 8604. 被引量:1
  • 10SLUPIANEK A, GURDEK E, KOPTYRA M, et al. BLM helicase is activated in BCR/ABL leukemia cells to modulate responses to eisplatin[ J]. Oncogene,2005,24(24) :3914-3922. 被引量:1

引证文献11

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部